Literature DB >> 22588741

Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA).

Jaclyn K Anderson1, Lani Zimmerman, Liron Caplan, Kaleb Michaud.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22588741     DOI： 10.1002/acr.20621

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN： 2151-464X            Impact factor:   4.794


× No keyword cloud information.
  77 in total

1.  Effect of Atorvastatin on the Disease Activity and Severity of Rheumatoid Arthritis: Double-Blind Randomized Controlled Trial.

Authors:  Karim Mowla; Elham Rajai; Ali Ghorbani; Mehrdad Dargahi-Malamir; Mohammad Bahadoram; Shooka Mohammadi
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 2.  [Self-monitoring in inflammatory rheumatic diseases].

Authors:  C Kampling; G Chehab; M Schneider; J G Richter
Journal:  Z Rheumatol       Date:  2014-10       Impact factor: 1.372

3.  Proportions of several types of plasma and urine microparticles are increased in patients with rheumatoid arthritis with active disease.

Authors:  V Viñuela-Berni; L Doníz-Padilla; N Figueroa-Vega; H Portillo-Salazar; C Abud-Mendoza; L Baranda; R González-Amaro
Journal:  Clin Exp Immunol       Date:  2015-04-27       Impact factor: 4.330

Review 4.  Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice.

Authors:  Jaclyn Anderson; Liron Caplan; Jinoos Yazdany; Mark L Robbins; Tuhina Neogi; Kaleb Michaud; Kenneth G Saag; James R O'Dell; Salahuddin Kazi
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

5.  Individual patient monitoring in daily clinical practice: a critical evaluation of minimal important change.

Authors:  Jos Hendrikx; Jaap Fransen; Wietske Kievit; Piet L C M van Riel
Journal:  Qual Life Res       Date:  2014-09-25       Impact factor: 4.147

6.  Factors Associated With Preterm Delivery Among Women With Rheumatoid Arthritis and Women With Juvenile Idiopathic Arthritis.

Authors:  Chelsey J F Smith; Frauke Förger; Gretchen Bandoli; Christina D Chambers
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-07-04       Impact factor: 4.794

7.  Predicting the probability of successful efficacy of a dissociated agonist of the glucocorticoid receptor from dose-response analysis.

Authors:  Daniela J Conrado; Sriram Krishnaswami; Satoshi Shoji; Sheela Kolluri; Judith Hey-Hadavi; Dorothy McCabe; Ricardo Rojo; Brinda K Tammara
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-05-13       Impact factor: 2.745

8.  Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA.

Authors:  E Aurrecoechea; J Llorca Díaz; M L Diez Lizuain; G McGwin; J Calvo-Alen
Journal:  Rheumatol Int       Date:  2016-12-16       Impact factor: 2.631

9.  The role of rheumatologists vis-à-vis assessment of traditional cardiovascular risk factors in rheumatoid arthritis.

Authors:  Yael Luck; Murray Baron; Sonia Bardakjian; Laeora Berkson; Maura Buchignani; Sabrina Fallavolita; Frédérique Giac; Geneviève Gyger; Solène Tatibouet; Marie Hudson
Journal:  Clin Rheumatol       Date:  2014-02-15       Impact factor: 2.980

10.  English language proficiency, health literacy, and trust in physician are associated with shared decision making in rheumatoid arthritis.

Authors:  Jennifer L Barton; Laura Trupin; Chris Tonner; John Imboden; Patricia Katz; Dean Schillinger; Edward Yelin
Journal:  J Rheumatol       Date:  2014-07       Impact factor: 4.666
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.